Cargando…
Management of HER2-Positive Early Breast Cancer in Italy: A Maze Presenting Opportunities and Challenges
The management of human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer (BC) has changed in recent years thanks to the introduction of anti-HER2 agents in clinical practice as standard of care in the neoadjuvant setting. In this scenario, we probed the issue of which HER...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160375/ https://www.ncbi.nlm.nih.gov/pubmed/35664788 http://dx.doi.org/10.3389/fonc.2022.871160 |